Ventricular arrhythmia (VA) and heart failure (HF) hospitalisation are major adverse outcomes in patients with cardiac sarcoidosis (CS). We aimed to identify clinical, laboratory and imaging predictors on the outcomes of these patients.
572 patients with a definite or probable diagnosis of CS according to...
V. Rossi, S. Anchise, G. Tersalvi et al.· European Heart Journal· 0 citations
BACKGROUND
Sex-based disparities in patient enrollment and treatment effects in heart failure (HF) randomized controlled trials (RCTs) have been reported. We aim to systematically analyze sex-based enrollment and treatment effect differences in HF RCTs over time.
METHODS
RCTs enrolling patients with chronic HF were s...
L. Fazzini, L. Pascalis, C. Madaudo et al.· European Journal of Heart Fa...· 0 citations
Background Apolipoprotein A-IV amyloidosis (AApoAIV) is a rare systemic amyloidosis that can involve the heart and mimic hypertrophic cardiomyopathy. Case Summary A 64-year-old woman with presumed hypertrophic cardiomyopathy presented with dyspnea. Imaging showed severe left ventricular wall thickening, outflow tract o...
R. Coderre, G. Tersalvi, R. Adigun et al.· JACC Case Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.